Retrospective Study Assessing Breast Cancer Occurrence and its Risk Factors among Females at Al Ahsa

S. Hassanein, E. Hassan, H. Mustafa, Khawlah Mohammed A Alnaim Sn, Nashwa Mohammed Al Dossari Sn
{"title":"Retrospective Study Assessing Breast Cancer Occurrence and its Risk Factors among Females at Al Ahsa","authors":"S. Hassanein, E. Hassan, H. Mustafa, Khawlah Mohammed A Alnaim Sn, Nashwa Mohammed Al Dossari Sn","doi":"10.4172/2471-9846.1000182","DOIUrl":null,"url":null,"abstract":"Background: Knowing incidence for, breast cancer, co-morbidities, diagnosis and treatment methods given a strategic approach for community awareness and rapid management. \nMethods: Retrospective cross-sectional descriptive design was utilized. Total of 183 confirmed breast cancer female patients from 2007-2014 were included but the available reviewed cases were 120. Females with any other type of cancer and any breast cancer (BC) case before 2007 were excluded. IRB approvals have been obtained. \nResults: Overall result showed that age of Breast cancer female patients ranged from 40-60 with mean (51.9 ± 14.4). The overall mean of Body Mass Index was (31.1 ± 07.6). The most common comorbidities associated with Breast Cancer females were diabetes, hypertension and heart disease (49.1%; 48.2% and 18.9%). Most Breast Cancer cases were diagnosed with infiltrating ductal carcinoma (79.3%). 48% of the discovered tumor was dominating in the left side of the breast (48.3%). 54.1% of BC females were diagnosed with a tumor size of 2-5cm (T2). 39.4% of BC cases were diagnosed as grade III. Most of the cases (80%) in 2007 were positive human epidermal growth factor receptor 2 (HER2) but it decreased to 27.3% positive cases in 2014. The disease manifestations were a mass in the breast -lump (98.2%), pain (98.2%) and lymph node involvement (66.4%).The first line of treatment used for those patients included mastectomy (79.6%), chemotherapy (67.9%), radiation (34.0%) and hormonal (15.0%). \nConclusion: Current study support and validate the scientific body of knowledge about BC in Saudi Arabia. Each year, the incidence rates increase specially for age above 50. According to Body Mass Index values, there were indications that the cases were obese. Diabetes, hypertension, and heart disease were the common co-morbidities among females with Breast Cancer. Cases of BC were managed by more than one approach such as surgery, chemotherapy, radiation, and hormonal treatment.","PeriodicalId":92236,"journal":{"name":"Journal of community & public health nursing","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2471-9846.1000182","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of community & public health nursing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2471-9846.1000182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Knowing incidence for, breast cancer, co-morbidities, diagnosis and treatment methods given a strategic approach for community awareness and rapid management. Methods: Retrospective cross-sectional descriptive design was utilized. Total of 183 confirmed breast cancer female patients from 2007-2014 were included but the available reviewed cases were 120. Females with any other type of cancer and any breast cancer (BC) case before 2007 were excluded. IRB approvals have been obtained. Results: Overall result showed that age of Breast cancer female patients ranged from 40-60 with mean (51.9 ± 14.4). The overall mean of Body Mass Index was (31.1 ± 07.6). The most common comorbidities associated with Breast Cancer females were diabetes, hypertension and heart disease (49.1%; 48.2% and 18.9%). Most Breast Cancer cases were diagnosed with infiltrating ductal carcinoma (79.3%). 48% of the discovered tumor was dominating in the left side of the breast (48.3%). 54.1% of BC females were diagnosed with a tumor size of 2-5cm (T2). 39.4% of BC cases were diagnosed as grade III. Most of the cases (80%) in 2007 were positive human epidermal growth factor receptor 2 (HER2) but it decreased to 27.3% positive cases in 2014. The disease manifestations were a mass in the breast -lump (98.2%), pain (98.2%) and lymph node involvement (66.4%).The first line of treatment used for those patients included mastectomy (79.6%), chemotherapy (67.9%), radiation (34.0%) and hormonal (15.0%). Conclusion: Current study support and validate the scientific body of knowledge about BC in Saudi Arabia. Each year, the incidence rates increase specially for age above 50. According to Body Mass Index values, there were indications that the cases were obese. Diabetes, hypertension, and heart disease were the common co-morbidities among females with Breast Cancer. Cases of BC were managed by more than one approach such as surgery, chemotherapy, radiation, and hormonal treatment.
评估Al-Ahsa女性癌症发生率及其危险因素的回顾性研究
背景:了解癌症的发病率、合并症、诊断和治疗方法为社区意识和快速管理提供了战略途径。方法:采用回顾性横断面描述性设计。2007-2014年间,共有183名确诊的癌症女性患者被纳入,但可用的审查病例为120例。排除2007年之前患有任何其他类型癌症和任何癌症(BC)病例的女性。已获得IRB批准。结果:癌症女性患者年龄40~60岁,平均(51.9±14.4),体重指数平均(31.1±07.6),高血压和心脏病(49.1%、48.2%和18.9%)。大多数癌症患者被诊断为浸润性导管癌(79.3%)。48%的发现肿瘤主要位于乳腺左侧(48.3%)。54.1%的BC女性被诊断为肿瘤大小为2-5cm(T2)。39.4%的BC病例被诊断为III级。2007年的大多数病例(80%)为人表皮生长因子受体2(HER2)阳性,但2014年降至27.3%。疾病表现为乳腺肿块(98.2%)、疼痛(98.2%和淋巴结转移(66.4%)。这些患者的一线治疗包括乳房切除术(79.6%)、化疗(67.9%)、放疗(34.0%)和激素(15.0%)。结论:目前的研究支持并验证了沙特阿拉伯关于乳腺癌的科学知识。每年,发病率都在增加,特别是50岁以上的人群。根据体重指数值,有迹象表明这些病例是肥胖的。糖尿病、高血压和心脏病是癌症女性的常见合并症。BC病例通过多种方法进行治疗,如手术、化疗、放疗和激素治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信